Literature DB >> 3514507

An outbreak of group A streptococcal bacteremia in an intensive care unit.

L E Nicolle, K Hume, H Sims, T Rosenal, D Sandham.   

Abstract

Admission of a patient with group A streptococcal cellulitis and bacteremia to the intensive care unit of a tertiary care teaching hospital was followed by two subsequent cases of group A streptococcal bacteremia with pneumonia in the unit. All streptococcal isolates were the same M- and T-type. Endotracheal intubation with respiratory ventilation was a risk factor for disease acquisition. The characteristics of onset of the two nosocomially acquired cases suggested that a staff member may have been, at least transiently, a streptococcal carrier, but no such carrier was identified. No further cases occurred subsequent to a period when all patients in the unit received antibiotics effective for group A streptococcal therapy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514507     DOI: 10.1017/s0195941700064031

Source DB:  PubMed          Journal:  Infect Control        ISSN: 0195-9417


  3 in total

1.  Group A beta-haemolytic streptococcus septicaemia: the toxic strep syndrome. Report of our cases developing septic shock and multiple organ failure.

Authors:  C Soravia; J A Romand; M Herrmann; J C Chevrolet; B Ricou; P M Suter
Journal:  Intensive Care Med       Date:  1993       Impact factor: 17.440

2.  Outbreak of Streptococcus pyogenes infection in healthcare workers in a paediatric intensive care unit: transmission from a single patient.

Authors:  M Montes; E Tamayo; E Oñate; E G Pérez-Yarza; E Pérez-Trallero
Journal:  Epidemiol Infect       Date:  2012-04-26       Impact factor: 4.434

Review 3.  Effectiveness and Safety of Antibiotic Prophylaxis for Persons Exposed to Cases of Invasive Group A Streptococcal Disease: A Systematic Review.

Authors:  Faizan Khan; Zemin Bai; Shannon Kelly; Becky Skidmore; Catherine Dickson; Alexandra Nunn; Katie Rutledge-Taylor; George Wells
Journal:  Open Forum Infect Dis       Date:  2022-05-12       Impact factor: 4.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.